Fabulous job Jeff and the NSCI and Luxa teams! We are excited to work with CIRM to grow our RPE program for patients with age-related macular degeneration.
We are thrilled to share that our Director of Translational Programs and Luxa Biotechnology LLC co-CEO, Dr. Jeffrey Stern, has been awarded a $4M grant from the California Institute for Regenerative Medicine (CIRM)! The award will be used to expand the ongoing Luxa-sponsored Phase 1/2a #ClinicalTrial testing our adult #stemcell therapy to treat dry Age-related #MacularDegeneration. Congratulations, Jeff and Luxa! Announcement | https://zurl.co/wonI Trial Info | https://zurl.co/YmFW
Congratulations Jeff and Sally, wishing you and Luxa much success in the trial for the benefit of AMD patients!
So excited and proud of you Jeff and Sally 🩷
HIGH POWER!
Sally Temple Jeffrey Stern Congratulations! Well deserved!!
Congratulations Jeff, Sally and the Luxa team! Well deserved.
Congratulations Jeff and Sally!
Congratulations Sally Temple and Jeffrey Stern!!!
Congratulations!!
Executive Director, Biomanufacturing and Associate Professor
2moCongratulations Jeff and Sally! We are glad to be part of the team, helping bring much needed regenerative cell therapies to the patients.